Clinical Trial Update: Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study evaluating ultra-high dose MR-guided stereotactic ablative radiotherapy for liver metastases, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Metastases | Phase 3 | Status: RECRUITING